Navigation Links
Could Weight Loss Be Early Sign of Alzheimer's?
Date:11/22/2011

By Amanda Gardner
HealthDay Reporter

MONDAY, Nov. 21 (HealthDay News) -- People with early evidence of Alzheimer's disease are more likely to be underweight than people who don't have this type of dementia, a new study suggests.

"Weight loss may be a manifestation of the disease process progressing," said Eric Vidoni, lead author of a study appearing in the Nov. 22 issue of Neurology. "This may be further evidence for body-wide or systemic changes associated with Alzheimer's disease ... and it certainly supports the idea that Alzheimer's disease-related changes could be silently occurring, i.e., a 'preclinical' phase."

The findings may hold implications for diagnosis, prevention or treatment, but these are likely to be years or even decades away.

"A long history of declining weight or BMI (body mass index, a ratio of weight to height) could aid the diagnostic process," said Vidoni, who is assistant director of the University of Kansas Alzheimer's Disease Center in Kansas CityIs.

At this point, though, it's too early "to make body composition part of the diagnostic toolbox," he added.

"If weight loss is part of the disease process, this could suggest, along with the many papers linking metabolic dysfunction with AD, that preventing such dysfunction could reduce the progression of AD," said Ian Murray, an assistant professor of neuroscience and experimental therapeutics at the Texas A&M Health Science Center College of Medicine. "Of course this is, at present, speculative."

Previous studies have found that people who are overweight in middle age or earlier have a higher risk of developing Alzheimer's. And those who are overweight in their later years actually may have a lower risk of Alzheimer's, something known as the "obesity paradox."

Vidoni and his partners looked at PET (positron emission tomography) imaging of the brain and analyzed cerebrospinal fluid for markers of Alzheimer's disease in 506 people. Participants represented a range of cognitive function, some with no memory problems, some with mild cognitive impairment and some with Alzheimer's.

People with evidence of Alzheimer's -- either in brain scans or protein levels in the cerebrospinal fluid -- were more likely to have a lower BMI than those who did not show early evidence of the disease.

And the markers of brain changes for Alzheimer's were most evident in people with normal memory functioning or mild cognitive impairment, although it's not clear yet why this is.

There are a number of theories -- but only theories at this point -- to explain the findings.

One is that the Alzheimer's disease process is affecting the hippocampus, that part of the brain involved in metabolism and appetite.

Or inflammatory processes may be driving both the decreased BMI and the cognitive changes.

More Information

The Alzheimer's Association has more on has more on this condition.

SOURCES: Eric Vidoni, Ph.D., assistant director, University of Kansas Alzheimer's Disease Center, Kansas City, Kan.; Ian Murray, Ph.D., assistant professor, neuroscience and experimental therapeutics, Texas A&M Health Science Center College of Medicine, College Station; Nov. 22, 2011, Neurology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Improved method of electrical stimulation could help treat damaged nerves
2. New smart material could help tap medical potential of tissue-penetrating light
3. Could Womens Use of the Pill Raise Mens Prostate Cancer Risk?
4. Burns app could save lives at the touch of a button
5. Regular Teeth Cleanings Could Cut Heart Attack Risk: Study
6. Greenhouse Gas Emissions Could Fall as Population Ages
7. Scientists discover how to design drugs that could target particular nerve cells
8. Computer Pathologist Could Help Assess Breast Cancer Survival
9. Early trial suggests rectal microbicide is safe, could significantly reduce HIV transmission
10. Birth cohort screening for hepatitis C is cost effective, could save thousands of lives each year
11. Wayne State therapeutic marijuana use study could impact state policies, guide treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Could Weight Loss Be Early Sign of Alzheimer's? 
(Date:2/23/2017)... FALLS CHURCH, Va. (PRWEB) , ... February 23, 2017 , ... ... , worries, or problems. He has also continued to spiritually evolve, which is the ... his published book “ Our Spiritual Truths ” (published by Balboa Press) attempts to ...
(Date:2/22/2017)... Los Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... medical detox treatment to the thousands of individuals who have recently fallen victim to ... accredited hospital in Orange County, California, where they are free from the shame, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well ... solution helps transform the HCC Risk Adjustment process from a typical fragmented ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier ... absorption from the mouth into the bloodstream. Far outpacing the absorption ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, ... is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... of neurosurgeons in Michigan performing minimally invasive back surgery that often results in ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... Mass. , Feb. 23, 2017   ... partner to global in vitro diagnostics manufacturers and ... series titled "Catalyzing Implementation of NGS-Based Tests" to ... March 30, 2017 at 11am Eastern Standard Time ... is to highlight the need for improved performance ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: